CD Genomics is a leading global life sciences company, and we remain committed to providing the research community with high-quality long-read sequencing services, from Oxford Nanopore to PacBio SMRT sequencing.
Cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) are both valuable biomarkers in liquid biopsies, but they differ in origin, biological significance, and clinical...
The use of next-generation amplicon sequencing technology has sparked debates within the microbiome research community due to its inherent limitations, primarily its short read...
